Published : 09 Mar 2020
Aagami has secured an innovative startup client to support their investment and partnering initiatives.
Aagami’s extensive knowledge and network since 2003 would be used to support this unique company with investors/companies from across the globe.
About the client:
· Are building technology enabled precision oncology solutions for cancer patients in Asia.
· These include use of Genomics Technology, Mobile technology, Patient derived models, and Data science.
· Through their unique set of solutions, they are building the largest curated data resource of genetic and real-world clinical outcome information of cancer patients from Asia starting from India.
· The First company ever from Indo-Pacific region to have been selected for the Illumina Accelerator program where they are developing new and unique solutions.
· Have secured a robust set of technology, clinical, community and research partnerships.
· Already generating revenue with continuous month on month growth.
· Are raising $1M through convertible note as of now. The fund will primarily be used for our operational expansion and improving the digital capability.